Idarubicin and High-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as idarubicin and cytarabine, work in different
ways to stop the growth of cancer cells, either by killing the cells or by stopping them from
dividing. Giving more than one drug (combination chemotherapy) may kill more cancer cells.
PURPOSE: This phase II trial is studying how well giving idarubicin together with high-dose
cytarabine works in treating patients with acute myeloid leukemia.